학술논문
1448P First-line nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC): Results from an interim analysis of the non-interventional FINN study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S823-S824
Subject
Language
ISSN
0923-7534